276 related articles for article (PubMed ID: 20525875)
1. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.
Talukder MA; Yang F; Shimokawa H; Zweier JL
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H437-45. PubMed ID: 20525875
[TBL] [Abstract][Full Text] [Related]
2. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.
Vladic N; Ge ZD; Leucker T; Brzezinska AK; Du JH; Shi Y; Warltier DC; Pratt PF; Kersten JR
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2130-9. PubMed ID: 21908789
[TBL] [Abstract][Full Text] [Related]
3. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.
Yin C; Salloum FN; Kukreja RC
Circ Res; 2009 Mar; 104(5):572-5. PubMed ID: 19213952
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
[TBL] [Abstract][Full Text] [Related]
5. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
7. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
Yang C; Talukder MA; Varadharaj S; Velayutham M; Zweier JL
Cardiovasc Res; 2013 Jan; 97(1):33-43. PubMed ID: 22977010
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
[TBL] [Abstract][Full Text] [Related]
9. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
10. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning.
Ciocci Pardo A; Scuri S; González Arbeláez LF; Caldiz C; Fantinelli J; Mosca SM
Cardiovasc Pathol; 2018; 33():19-26. PubMed ID: 29414428
[TBL] [Abstract][Full Text] [Related]
11. Ischemic preconditioning prevents in vivo hyperoxygenation in postischemic myocardium with preservation of mitochondrial oxygen consumption.
Zhu X; Liu B; Zhou S; Chen YR; Deng Y; Zweier JL; He G
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1442-50. PubMed ID: 17513495
[TBL] [Abstract][Full Text] [Related]
12. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.
Bell RM; Yellon DM
Cardiovasc Res; 2001 Nov; 52(2):274-80. PubMed ID: 11684075
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia.
Ge ZD; Ionova IA; Vladic N; Pravdic D; Hirata N; Vásquez-Vivar J; Pratt PF; Warltier DC; Pieper GM; Kersten JR
Cardiovasc Res; 2011 Jul; 91(2):340-9. PubMed ID: 21422102
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.
Baotic I; Ge ZD; Sedlic F; Coon A; Weihrauch D; Warltier DC; Kersten JR
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H219-27. PubMed ID: 23666677
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
16. Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart.
Charan K; Goyal A; Gupta JK; Yadav HN
J Surg Res; 2016 Apr; 201(2):272-8. PubMed ID: 27020807
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
[TBL] [Abstract][Full Text] [Related]
18. Sirtinol abrogates late phase of cardiac ischemia preconditioning in rats.
Safari F; Shekarforoosh S; Hashemi T; Namvar Aghdash S; Fekri A; Safari F
J Physiol Sci; 2017 Jul; 67(4):515-522. PubMed ID: 27677982
[TBL] [Abstract][Full Text] [Related]
19. Effect of maturation on the resistance of rat hearts against ischemia. Study of potential molecular mechanisms.
Griecsová L; Farkašová V; Gáblovský I; Khandelwal VK; Bernátová I; Tatarková Z; Kaplan P; Ravingerová T
Physiol Res; 2015; 64(Suppl 5):S685-96. PubMed ID: 26674286
[TBL] [Abstract][Full Text] [Related]
20. Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.
Kristiansen SB; Pælestik KB; Johnsen J; Jespersen NR; Pryds K; Hjortbak MV; Jensen RV; Bøtker HE
Cardiovasc Diabetol; 2019 May; 18(1):66. PubMed ID: 31151453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
